AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 101 filers reported holding AVROBIO INC in Q1 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $11,064,000 | +7.1% | 793,712 | 0.0% | 0.10% | -25.4% |
| Q3 2020 | $10,334,000 | -25.4% | 793,712 | 0.0% | 0.13% | -33.3% |
| Q2 2020 | $13,850,000 | +34.2% | 793,712 | +19.7% | 0.20% | +12.7% |
| Q1 2020 | $10,319,000 | -19.2% | 663,174 | +4.5% | 0.17% | -4.9% |
| Q4 2019 | $12,777,000 | +58.6% | 634,700 | +11.2% | 0.18% | +19.0% |
| Q3 2019 | $8,058,000 | +367.4% | 570,700 | +438.4% | 0.15% | +466.7% |
| Q2 2019 | $1,724,000 | -60.6% | 106,000 | -46.6% | 0.03% | -60.3% |
| Q1 2019 | $4,379,000 | +5.2% | 198,583 | -20.5% | 0.07% | -11.7% |
| Q4 2018 | $4,161,000 | -67.9% | 249,900 | -0.0% | 0.08% | -50.6% |
| Q3 2018 | $12,968,000 | +81.6% | 250,000 | 0.0% | 0.16% | +83.5% |
| Q2 2018 | $7,140,000 | – | 250,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |